𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck

✍ Scribed by John D. Hainsworth; David R. Spigel; Howard A. Burris III; Tiffanie M. Markus; Dianna Shipley; Michel Kuzur; Scott Lunin; F. Anthony Greco

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
228 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neoadjuvant chemotherapy followed by con
Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3–T4) oropharyngeal squamous cell carcinoma
✍ Veronica Finnegan; James T. Parsons; Bruce D. Greene; Vinay Sharma πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 104 KB

## Abstract ## Background Radiation therapy (RT) is commonly used in the management of patients with advanced (T3–T4) oropharyngeal squamous cell carcinomas. In recent years, based upon the meta‐analyses of randomized trials, chemotherapy administered concurrently with RT (chemoradiotherapy) has b

Concurrent platinum-based chemotherapy a
Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base
✍ Joshua D. Lawson; Kristen Otto; Amy Chen; Dong M. Shin; Lawrence Davis; Peter A. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 178 KB πŸ‘ 1 views

## Abstract ## Background. Randomized data support use of chemotherapy concurrently with radiation in treatment of advanced squamous cell carcinoma (SCC) of the oropharynx. Intensity modulated radiation therapy (IMRT) is increasingly being used to deliver such radiotherapy; no published reports sp

Cost utility of docetaxel as induction c
Cost utility of docetaxel as induction chemotherapy followed by chemoradiation in locally advanced squamous cell carcinoma of the head and neck
✍ Anju Parthan; Marshall R. Posner; Caroline Brammer; Philippe Beltran; Jeroen P. πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 177 KB πŸ‘ 1 views

## Abstract ## Background Trial TAX 324 showed that induction chemotherapy with docetaxel plus cisplatin and 5‐fluorouracil (TPF) compared with cisplatin and 5‐fluorouracil (PF) followed by chemoradiation increases survival and time to progression in squamous cell carcinoma of head and neck (SCCHN

Concurrent chemotherapy with intensity-m
Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: A retrospective single-institution analysis
✍ Nabil F. Saba; Scott Edelman; Mourad Tighiouart; Jennifer Gaultney; Lawrence W. πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 240 KB πŸ‘ 1 views

## Abstract ## Background We present outcome data from concurrent chemotherapy and intensity‐modulated radiation therapy (IMRT) for squamous cell carcinoma (SCC) of the larynx and oropharyx. ## Methods Eighty patients with laryngeal (__n__ = 15) or oropharyngeal (__n__ = 65) SCC underwent concur

Cisplatin, tegafur, and leucovorin : A m
Cisplatin, tegafur, and leucovorin : A moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck
✍ Hung-Ming Wang; Cheng-Su Wang; Jen-Shi Chen; I-How Chen; Chun-Ta Liao; Tung-Chie πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 1 views

## Abstract ## BACKGROUND To evaluate the efficacy and toxicity of cisplatin, tegafur, and leucovorin as neoadjuvant chemotherapy (CT) for patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck (SCCHN). ## METHODS Patients with SCCHN according to World Health Organiza